Design, Synthesis, and Biological Evaluation of Novel 2<i>H</i>-Pyran-2-one Derivatives as Potential HIV-1 Reverse Transcriptase Inhibitors
作者:Andrea Defant、Ines Mancini、Rossella Tomazzolli、Jan Balzarini
DOI:10.1002/ardp.201400235
日期:2015.1
effective drugs against HIV infection acting as non‐nucleoside reverse transcriptase inhibitors (NNRTIs), a series of new molecules with hybrid structures based on the natural product (+)‐calanolide A and the synthetic molecule α‐APA, known as potent and selective inhibitors of this enzyme, were selected by docking calculations. A convergent synthetic strategy gave 21 compounds with a 2H‐pyran‐2‐one structural
为了寻找更有效的抗 HIV 感染药物,作为非核苷逆转录酶抑制剂 (NNRTIs),一系列具有基于天然产物 (+)-calanolide A 和合成分子 α-APA 的混合结构的新分子,称为通过对接计算选择了这种酶的有效和选择性抑制剂。聚合合成策略得到了 21 种具有 2H-吡喃-2-one 结构单元并带有等排修饰的化合物,这些化合物在 HIV 感染的 CEM 细胞培养物中进行了测试。只有化合物 6 (4-((2-(1H-indol-3-yl)ethyl)amino)-6-methyl-2H-pyran-2-one) 显示出抑制活性 (EC50: 25-50 µM)。然而,它与对人 T 淋巴细胞 (CEM) 细胞培养物的相对较高的细胞抑制作用有关,无论是化学结构还是计算方法,都不容易预测。